PPTA Twitter

PlasmaProteins #Plasma goes through a complex manufacturing process known as fractionation where proteins are separated to develop #plasmaprotein therapies. Learn more about the process: bit.ly/2ytTQCI pic.twitter.com/ZYK7nzwrvi

2 days ago.

PlasmaProteins Next month, @PlasmaProteins will hold its annual Fly-In on Capitol Hill! PPTA, its membership, and stakeholders will advocate for patient protections & the importance of prohibitions on lifetime and annual caps for people who need #plasmaprotein therapies. bit.ly/2FRKqnR

3 days ago.

Ethical Considerations in Compensated Plasma Donation

PPTA's standards programs are cited in "Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products," in Transfusion. This Commentary concludes that there is no ethical basis for banning compensated plasma donation. Click here for the full article.

PPTA News

Register now for the 2019 Plasma Protein Forum! +

The 2019 Plasma Protein Forum will be held Tuesday, June 18 - Wednesday, June 19 at the Hyatt Regency Reston in Reston, Virginia, U.S.

Online registration closes
June 14--Register now!
Read More
PPTA Responds to New York Times Article +

On February 1, The New York Times published an article that lacked balance in its portrayal of Source plasma donors. Plasma donors, including Jacqueline Watson, Kevin Hayway, and Robert Jenkins, all of whom are discussed in the article, deserve our deepest respect, gratitude, and appreciation, not negative characterizations and insinuation.
Read More
PPTA Names Amy Efantis President & CEO +

Annapolis, MD (January 14, 2019) -- The Board of Directors of the Plasma Protein Therapeutics Association (PPTA) announced today that Amy Efantis will be its next President and Chief Executive Officer effective January 16, 2019.

Having served most recently as Vice President, Global Public Policy & Government Affairs at Biogen, Efantis joins the PPTA, the world’s leading trade association that represents more than 750 human plasma collection centers in North America and Europe as well as the manufacturers of life-saving plasma protein therapies.
Read More